Aditi

Too insignificant for introduction.

[MedicinesPatentPool @MedsPatentPool]

Following the MPP-ViiV agreement on #dolutegravir in late 2020, we're pleased to announce progress in the fight against #HIV in Azerbaijan🇦🇿, Belarus🇧🇾, Kazakhstan🇰🇿 & Malaysia🇲🇾👇

✅ In Belarus & Kazakhstan, the volumes of DTG procured by national HIV programmes can cover 78% and 86% of people on #ART respectively.
✅ Azerbaijan is making strides to reach 65%of people on ART with DTG treatments this year🎉
✅Malaysia is planning to accelerate the transition to TLD starting from 2025.

These achievements were made possible by price reductions ↘️  of over 90% and are a result of the dedication of many, incl communities, healthcare professionals & governments.

Read our statement 👉 https://t.co/K4WGMquPSq
#GlobalHealth #Access2Meds

[Aditi @simplyaditi]

@Paytmcare @Paytmcare please acknowledge the receipt of details and do the needful. We are facing extreme inconvenience because of the issues with fast tag.

[Aditi @simplyaditi]

@Paytmcare Hey can you please help in deactivating my fast tag from Paytm ? Your app link does not work at all! Without deactivating, I cannot get new one.

[Aditi @simplyaditi]

@Paytmcare I have sent you my details . Please do the needful at the earliest.

[MedicinesPatentPool @MedsPatentPool]

🤩Attending #AORTIC2023? Our team will be at @AORTIC_AFRICA in #Dakar🇸🇳‼️

🗣️Join us at:
☑️our MPP-sponsored session with @eburrone on how we can achieve faster and more sustainable access to innovative #cancer medicines?
☑️hear from @GiuliaESSE during the 🫂community-led session on access to #medicines💊, how can we solve this enigma?
☑️Visit our booth #7 in the Exhibition Area

[Aditi @simplyaditi]

@GoFirstairways That’s what I wrote that even after following everything no refund have been initiated. Do you all have any real intentions of refunding public money ?

[Aditi @simplyaditi]

@GoFirstairways Hey even after 3 months I have not received refund. Please note that all due forms have been filed by MMT, so don’t give the standard answer copying the link for NCLT forms. Honestly do you all intend to give public money back ?

[MedicinesPatentPool @MedsPatentPool]

🗣️“I’m committed to the principle that people in LMICs deserve the best medicines as quickly as people in high-income countries,” shared our ED, @CharlieGore to @TheCEOMagazineG

Read the article👇🏼
https://t.co/ckJWHYtF2L

[AlliancePublicHealth @allianceforph]

Join the discussion and online presentation of the policy brief "ARV price reduction mechanisms in Eastern Europe and Central Asia".

🗓 Date: August 10
🕓 Time: 11:30 to 13:00 (EEST, UTC +3)
Pre-registration: https://t.co/BahSiU16My

[Aditi @simplyaditi]

@ManipalCigna I have been struggling to raise a claim for myself for last two days! Neither your website nor your app is functioning to download claim forms. Repeated calls to customer care , including emails with no resolution yet. Can you look into this on priority?

[MedicinesPatentPool @MedsPatentPool]

⏰Countdown to #IAS2023 is on 🚀

Join us in #Brisbane🇦🇺 and virtually for our Satellite Sessions as we discuss:

☑️advancing #HIV care for mothers and newborns
☑️long-acting injectable #cabotegravir (CAB-LA) as #PrEP in Asia

Discover More 👉🏽 https://t.co/4dMZVPfVYr

[MedicinesPatentPool @MedsPatentPool]

📃#LatestPublication｜@jiasociety has just published a paper by MPP co-authors on voluntary licensing of long-acting #HIV prevention and treatment regimens in #LMICs.

Access the paper ➡️ https://t.co/D4Zx0VtCIW
Watch Our Video to Learn More 👇🏽
https://t.co/iG4t49hRIW

[MedicinesPatentPool @MedsPatentPool]

#Breaking | 4⃣ generic manufacturers✍️🏽sign sublicence agreements with MPP to produce generic versions of @Novartis’ #nilotinib for the treatment of chronic myeloid #leukaemia.

Access our #PressRelease 👉🏽 https://t.co/vIfR8S7XOL

#HealthForAll #Access2Meds #PublicHealth #cancer

[Union for International #CancerControl @uicc]

PODCAST: Inequities in access to essential medicines and global shortages

Hans Hogerzeil, former Director of Essential Medicines at @WHO, and @CharlieGore, CEO of @MedsPatentPool shed light on this complex problem and explore potential solutions.

➡️ https://t.co/67F24oeEFF

[AVAC @HIVpxresearch]

Why do we need licenses and technology transfer to ensure equity in global health access and impact? BECAUSE!! Check out these five reasons from Esteban Burrone from @MedsPatentPool ⬇️

[MedicinesPatentPool @MedsPatentPool]

#HappeningNow at #Afrigen🇿🇦｜MPP ED
@CharlieGore is meeting w/ Dawn O'Connell (@HHS_ASPR), Assistant Secretary for Preparedness and Response leading @ASPRgov 🇺🇸.

👉🏽to discuss the #mRNA tech transfer programme & how it supports global efforts for #PandemicPrepardness & response.

[MedicinesPatentPool @MedsPatentPool]

‼️MPP's Head of Policy, Strategy and Market Access @eburrone will be speaking at @HIVpxresearch's upcoming panel discussion on "Global PPPR Equity: Why do we need agreements on #IP and tech transfers?"
⏰ 6 April 9am ET / 3pm CET
👉🏽Register: https://t.co/dihTkCJ6d1

[MedicinesPatentPool @MedsPatentPool]

#Breaking｜The Medicines Patent Pool signs sublicences with #Aurobindo, @Cipla_Global and @ViatrisInc to produce generic versions of @ViiVHC’s innovative long-acting #HIV prevention medicine.

Access the MPP-ViiV joint #PressRelease > https://t.co/oJPGFBXBbO

#PublicHealth

[CELT Global Health @CELTLiverpool]

The #LongActing Therapeutics Patents & Licences Database is now available with enhanced features to track new drug development!

#LAPaL is hosted by @MedsPatentPool in collaboration with CELT and supported by @Long_Acting_HIV & @Unitaid

Find out more👉https://t.co/NOy9e16pTl

[MUMBAI NEWS @Mumbaikhabar9]

This 2 year old boy Shravan Gyaneshwar Bagul was found in local train between Mumbai CSMT & Ray Road station. He is from Nashik. Any information regarding him can be communicated to concerned police official at 02267455770 or 8291272999.